TY - JOUR
T1 - Digital Cardiology
T2 - Opportunities for Disease Prevention
AU - Vervoort, Dominique
AU - Marvel, Françoise A.
AU - Isakadze, Nino
AU - Kpodonu, Jacques
AU - Martin, Seth S.
N1 - Funding Information:
This paper did not receive specific funding. Dr. Marvel, Dr. Isakadze, and Dr. Martin have received research funding related to digital cardiology from the American Heart Association. Dr. Marvel and Dr. Martin have received material support from Apple, iHealth, and Nokia, and funding from the Maryland Innovation Initiative, Wallace H. Coulter Translational Research Partnership, Louis B. Thalheimer Fund, and the Johns Hopkins Individualized Health Initiative. Dr. Martin also reports research support from the Aetna Foundation, the David and June Trone Family Foundation, Google, the National Institutes of Health, and the PJ Schafer Memorial Fund.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - Purpose of Review: Cardiovascular diseases (CVD) are the world’s leading cause of mortality, responsible for 18 million deaths each year. Disease prevention is a critical component to curb the morbidity and mortality due to CVD worldwide, and advances in digital health technologies may facilitate adherence to and effectiveness of preventive measures. In this review, we seek to identify and describe recent developments in the use of digital health for CVD prevention between 2015 and 2019. Recent Findings: Promising digital health technologies have emerged in the field of cardiology. In the diagnostics arena, AliveCor has shown to obtain real-time electrocardiograms via smartphones, whereas the Apple Watch proved efficacious to detect atrial fibrillation. In the treatment arena, the Corrie Health Digital Platform may enable myocardial infarction patients to benefit from remote cardiac rehabilitation and secondary prevention. Emerging technologies such as virtual reality, artificial intelligence, and machine learning suggest further potential for the growth and clinical relevance of digital cardiology. Summary: Digital health technologies have become increasingly popular in the repertoire to prevent CVD. Although caution is warranted given the concurrent surge of unregulated smartphone applications and other technologies, digital cardiology presents important potential to reduce the global burden of CVD.
AB - Purpose of Review: Cardiovascular diseases (CVD) are the world’s leading cause of mortality, responsible for 18 million deaths each year. Disease prevention is a critical component to curb the morbidity and mortality due to CVD worldwide, and advances in digital health technologies may facilitate adherence to and effectiveness of preventive measures. In this review, we seek to identify and describe recent developments in the use of digital health for CVD prevention between 2015 and 2019. Recent Findings: Promising digital health technologies have emerged in the field of cardiology. In the diagnostics arena, AliveCor has shown to obtain real-time electrocardiograms via smartphones, whereas the Apple Watch proved efficacious to detect atrial fibrillation. In the treatment arena, the Corrie Health Digital Platform may enable myocardial infarction patients to benefit from remote cardiac rehabilitation and secondary prevention. Emerging technologies such as virtual reality, artificial intelligence, and machine learning suggest further potential for the growth and clinical relevance of digital cardiology. Summary: Digital health technologies have become increasingly popular in the repertoire to prevent CVD. Although caution is warranted given the concurrent surge of unregulated smartphone applications and other technologies, digital cardiology presents important potential to reduce the global burden of CVD.
KW - Cardiology
KW - Digital health
KW - Prevention
UR - http://www.scopus.com/inward/record.url?scp=85087147074&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087147074&partnerID=8YFLogxK
U2 - 10.1007/s12170-020-00644-6
DO - 10.1007/s12170-020-00644-6
M3 - Review article
AN - SCOPUS:85087147074
SN - 1932-9520
VL - 14
JO - Current Cardiovascular Risk Reports
JF - Current Cardiovascular Risk Reports
IS - 8
M1 - 10
ER -